SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

A stronger-than-expected third-quarter report and managements upbeat 2027 outlook have driven CLFs sharp rally, with bullish traders focused on improved steel pricing and possible short covering. Others question whether the outlook can overcome the companys debt and execution concerns, and some view the move as a sell-the-news bounce.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade to Buy after a sharp selloff fueled hopes of a rebound, but traders debated whether the upgrade could overcome ongoing financing concerns, especially as the rally faded. Bulls point to AI demand, customer commitments and Nvidias support, while bears remain focused on CoreWeaves heavy debt burden and borrowing costs.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The FDAs early expansion of ANKTIVA plus BCG to papillary-only BCG-unresponsive bladder cancer, alongside long-term data showing durable responses, is driving discussion about a larger patient market and future sales. Traders are puzzled by the share-price decline despite the positive developments, debating a sell-the-news reaction and broader biotech weakness versus unverified claims of short-selling or options-related pressure.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are under heavy pressure amid IPO lockup-related selling concerns and a broader AI and semiconductor pullback, with traders also questioning the companys valuation, growth, and ability to scale. Bears expect further downside as more shares become eligible for sale, while bulls view the selloff as excessive and are averaging in.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are under pressure amid a sharp pullback, with traders pointing to repeated insider sales and a reported DBS downgrade as potential reasons for the weakness; some also cite broader Indonesia and Southeast Asia market concerns. Bulls argue the selling was planned and the business remains strong, while bears see insider selling and weak price action as warning signs.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons advance is drawing attention after Morgan Stanley named it a top pick, citing AWS growth, AI opportunities and warehouse automation as potential catalysts. Traders are broadly bullish on the move, though some remain cautious about heavy AI spending and whether the shares can sustain gains ahead of earnings.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine shares are surging after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, supporting a planned FDA resubmission. Traders are broadly reacting positively, while debating short-squeeze potential and flagging dizziness and sharp price swings as concerns.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

Sharp post-IPO selling and volatile trading dominate the discussion, with traders pointing to lockup-related supply, bearish analyst coverage, and weakness across nuclear stocks as possible pressures. Bulls are treating the pullback as an opportunity, citing Amazons backing and X-energys potential role in meeting future data-center power demand, while others stress that reactor commercialization remains years away.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention after a sharp selloff alongside other AI neocloud stocks, as traders debate financing costs and whether the sectors growth can justify its heavy capital needs. Some see the rebound and analyst support as a buying opportunity, while others call it a short-lived bounce and expect more pressure.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Attention centers on the FDA-cleared expansion of Alpha Taus REGAIN trial for recurrent glioblastoma and anticipated clinical data at the SNO meeting. Traders are bullish on early tumor-control findings and the broader pipeline, though some note the evidence comes from a small initial cohort.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

D-Wave Quantum Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights QBTS

The DJS Law Group reminds investors of a class action lawsuit against D-Wave Quantum Inc. (D-Wave or the Company) (NASDAQ: QBTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders...

QBTS Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against D-Wave Quantum Inc.

QBTS Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against D-Wave Quantum Inc. QBTS Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against D-Wave Quantum Inc.PR NewswireSAN DIEGO, Oct. 16, 2026 SAN DIEGO, Oct. 16, 2026 /PRNewswire...

QBTS Investors Have Opportunity to Lead D-Wave Quantum Inc. Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against D-Wave Quantum Inc. (D-Wave or the Company) (NASDAQ: QBTS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated...

QBTS INVESTOR ALERT: D-Wave Quantum Inc. Investors with Substantial Losses May Seek to Lead the D-Wave Class Action Lawsuit

QBTS INVESTOR ALERT: D-Wave Quantum Inc. Investors with Substantial Losses May Seek to Lead the D-Wave Class Action Lawsuit QBTS INVESTOR ALERT: D-Wave Quantum Inc. Investors with Substantial Losses May Seek to Lead the D-Wave Class Action LawsuitPR NewswireSAN DIEGO, Oct. 16, 2026 SAN DIEGO, Oct...

Rigetti Falls 21% in the Past Month: Hold or Fold the Stock Now?

RGTI's shares have plunged 21% in a month, as widening losses and valuation concerns clash with strong liquidity, government funding and quantum growth prospects.

Investor Alert: Robbins LLP Informs Investors of the D-Wave Quantum Inc. Class Action Lawsuit

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons who purchased or otherwise acquired D-Wave (NYSE: QBTS) securities between February 26, 2026 and August 25, 2026, inclusive (the Class Period). D-Wave is a company engaged in quantum...

Could Investing $5,000 in D-Wave Quantum Stock Today Make You a Millionaire?

Key PointsMany expect quantum computing to be the next big tech revolution...

D-Wave Delivers Italys First Annealing Quantum Computer

D-Wave Quantum Inc. (NASDAQ: QBTS) (D-Wave or the Company), the only dual-platform quantum computing company providing annealing and gate-model systems, software and services, today announced at Digital Innovation Forum 2026 that its Advantage2TM annealing quantum computer has arrived in Lombardy...

3 Quantum Computing Stocks in the Limelight After October Deals

IonQ, Xanadu and D-Wave gain attention as October deals, manufacturing partnerships and product initiatives offer fresh catalysts for quantum commercialization.

D-Wave Quantum Extends Key Manufacturing Alliance

D-Wave Quantum extends its SkyWater manufacturing partnership to boost next-gen quantum chip production. QBTS stock down 2%.read more...

• Reported GAAP EPS of -$0.13 up 76.36% YoY
• Reported revenue of $3.08M down -0.61% YoY

D-Wave Quantum Inc. experienced margin compression, a 93% increase in GAAP operating expenses, and a 33% decline in cash and marketable investment securities compared to the prior year period.

D-Wave Quantum Inc. achieved 1,120% growth in first-half bookings, a 668% increase in remaining performance obligations, and received industry recognition as a Leader in the 2026 IDC MarketScape assessment.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS, RGTI, QNT Stocks Rally After $100M Quantum Deals: US Government Takes Stakes In All Three

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Each company has finalized a $100 million funding agreement with the U.S. Department of Commerce under the CHIPS and Science Act.</li><li>The government will receive a minority, non-controlling equity stake in each company in exchange for the funding.</li><li>The funding aims to address some of quantum computing’s biggest challenges, including scaling, reliability, manufacturing and supply-chain development.</li></ul>Shares of D-Wave Quantum (QBTS), Rigetti Computing (RGTI) and Quantinuum (QNT) rallied in early morning trade on&nbsp;Tuesday&nbsp;despite weakness in the broader market after&nbsp;the U.S. government finalized putting $100 million each behind the companies in a push to develop quantum computing.The government’s&nbsp;Department&nbsp;of Commerce will receive a minority, non-controlling equity stake in each company in exchange for the funding.&nbsp;<a href="https://stocktwits.com/symbol/QBTS">QBTS stock</a> rose over 4% in pre-market trade, while&nbsp;<a href="https://stocktwits.com/symbol/RGTI">RGTI stock</a> rallied as much as 7%.&nbsp;<a href="https://stocktwits.com/symbol/QNT">QNT shares</a> gained around 2.6%, still outperforming the broader market. The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) edged 0.26% lower ahead of&nbsp;the&nbsp;market’s opening, while the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF</a> (DIA) slipped 0.75% and the Nasdaq-100 tracking&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) traded flat.&nbsp;RGTI and QBTS stocks&nbsp;were&nbsp;among the top trending tickers on Stocktwits at the time of writing. However, retail sentiment around them remained in ‘bearish’ territory over the past day.<h2 class="st-heading-2">Government Targets Quantum's Biggest Challenge</h2>Quantum computers are expected eventually tackle problems that are difficult or impossible for conventional computers, with potential applications in areas including drug discovery, materials science, cryptography, optimization and artificial intelligence.However, the technology remains difficult and expensive to scale. The companies are using different approaches to solve that problem, and all three government agreements focus heavily on moving quantum computing toward larger and more practical systems.<h2 class="st-heading-2">Where Does The $100M Go?</h2>Rigetti is using its $100 million award to address three hardware challenges. This includes shrinking the electronics used to read quantum chips, dramatically expanding the capacity of the extremely cold environments quantum computers require, and developing chips that allow more quantum bits, or qubits, to communicate with one another.D-Wave will use up to $100 million to develop both its quantum annealing and gate-model systems. Its targets include a 100,000-qubit annealing system and a 10,000-qubit gate-model system designed to deliver 100 logical qubits.Quantinuum, meanwhile, will use its $100 million award to scale its trapped-ion quantum technology, another approach to building quantum computers. The company plans to work with GlobalFoundries (GFS) to manufacture next-generation ion traps and electronics using 300mm wafers, while Monarch Quantum will help develop lasers and optical components.<a href="https://stocktwits.com/symbol/GFS">GFS stock</a> gained over 1% in pre-market trade, with retail sentiment on Stocktwits trending in ‘bearish’ territory over the past day.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intc-stock-jumps-intel-asml-high-na-euv-tsmc-samsung/cZt3vOqRJUg">Samsung, TSMC Commit To ASML's Next-Gen Chip Machines, But Intel Got There First</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

3D illustration of a working quantum computer. Quantum computing concept (Photo by adventtr via Getty Images).

The U.S. government is committing a combined $300 million to D-Wave Quantum, Rigetti Computing and Quantinuum.

Quantinuum Inc.

Defiance Quantum ETF

Rigetti Computing Inc

Yes, still bullish

No, losing confidence

Waiting to see earnings first

Never was bullish

Quantum computing stocks - like $IONQ, $RGTI, and $QBTS - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

Stocktwits

IonQ Inc

 - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

Current Price	$11.93
Prev Close	$11.78
Open	$12.20
Dividend Yield	0.00%
50-Day Moving Average	$17.16
Beta	2.85
Avg. Volume	15.86M
PE Ratio	-16.63

52-Week High	$39.68
52-Week Low	$11.35
Market Capitalization	$4.47B
EPS (Annual)	-$1.11
Price to Book	4.05
Revenue Per Employee	$63,368.56

Feed

News

Sentiment

Earnings

Fundamentals

Info

QBTS Fundamentals